Mayer Davidson to Reproducibility of Results
This is a "connection" page, showing publications Mayer Davidson has written about Reproducibility of Results.
Connection Strength
0.525
-
Davidson MB. Evaluation of self monitoring of blood glucose in non-insulin-treated diabetic patients by randomized controlled trials: little bang for the buck. Rev Recent Clin Trials. 2010 Sep; 5(3):138-42.
Score: 0.073
-
Davidson MB. Novel noninvasive breath test method for screening individuals at risk for diabetes: response to Dillon et al. Diabetes Care. 2009 Jul; 32(7):e88; author reply e89.
Score: 0.067
-
Davidson MB, Ansari A, Karlan VJ. Effect of a nurse-directed diabetes disease management program on urgent care/emergency room visits and hospitalizations in a minority population. Diabetes Care. 2007 Feb; 30(2):224-7.
Score: 0.057
-
Davidson MB. Counterpoint: Self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: a waste of money. Diabetes Care. 2005 Jun; 28(6):1531-3.
Score: 0.051
-
Davidson MB. Early insulin therapy for type 2 diabetic patients: more cost than benefit. Diabetes Care. 2005 Jan; 28(1):222-4.
Score: 0.049
-
Roy R, Navar M, Palomeno G, Davidson MB. Real world effectiveness of rosiglitazone added to maximal (tolerated) doses of metformin and a sulfonylurea agent: a systematic evaluation of triple oral therapy in a minority population. Diabetes Care. 2004 Jul; 27(7):1741-2.
Score: 0.047
-
Davidson MB, Landsman PB, Alexander CM. Lowering the criterion for impaired fasting glucose will not provide clinical benefit. Diabetes Care. 2003 Dec; 26(12):3329-30.
Score: 0.046
-
Davidson MB. Editor's comment: "It ain't necessarily so". Diabetes Care. 2002 Nov; 25(11):2116.
Score: 0.042
-
Davidson MB. Counterpoint: the oral glucose tolerance test is superfluous. Diabetes Care. 2002 Oct; 25(10):1883-5.
Score: 0.042
-
Davidson MB. Have we got the new diagnostic criteria for diabetes and impaired glucose states right? No. Curr Diab Rep. 2002 Feb; 2(1):3-4.
Score: 0.040
-
Brandle M, Davidson MB, Schriger DL, Lorber B, Herman WH. Cost effectiveness of statin therapy for the primary prevention of major coronary events in individuals with type 2 diabetes. Diabetes Care. 2003 Jun; 26(6):1796-801.
Score: 0.011